On April 18th BC PharmaCare announced that it was expanding its existing coverage of medications for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in the paediatric population only. Three long acting ADHD medications (Adderall XR, Vyvanse and Strattera) will be added under the Special Authority (SA) program. CADDRA and CADDAC along with BC medical practitioners welcome these expanded medication options for children. However, British Columbia continues to lag significantly behind other provinces by denying coverage to individuals over 19, thereby discriminating against adults with ADHD.
Read More on our Blog
May 2, 2017 Media Release
I grew up knowing I was a little different. I was... Read More
My name is Diane and I have ADHD. I was diagnosed... Read More
The ADHD diagnosis of a child is often a pivotal m... Read More
My name is Veronica, and I was a working mom to a... Read More
Life inside an ADHD brain can be…unpleasant at tim... Read More
